Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome Instability
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome Instability
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-30
DOI
10.3389/fendo.2018.00706
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis
- (2018) Lin Li et al. OncoTargets and Therapy
- miR-218 inhibited tumor angiogenesis by targeting ROBO1 in gastric cancer
- (2017) Xiangyuan Zhang et al. GENE
- STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization
- (2017) Yuichi Kitai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Elevated expression of Erbin destabilizes ERα protein and promotes tumorigenesis in hepatocellular carcinoma
- (2017) Hua Wu et al. JOURNAL OF HEPATOLOGY
- Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies
- (2017) Hiroki Ide et al. PLoS One
- Dysregulated expression of inflammation-related genes in psoriatic dermis mesenchymal stem cells
- (2016) Xuping Niu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy
- (2016) Lan Yu et al. INTERNATIONAL JOURNAL OF CANCER
- Type 2 diabetes alters mesenchymal stem cell secretome composition and angiogenic properties
- (2016) Jonathan Ribot et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival
- (2016) Débora R. Bublik et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion
- (2016) Erin A. Maine et al. Oncotarget
- Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth
- (2015) E. Delgrange et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer
- (2015) Hong Yuen Wong et al. Oncotarget
- The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy
- (2014) Youwei Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer
- (2014) Lars A Forsberg et al. NATURE GENETICS
- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
- (2013) Jacqueline Trouillas et al. ACTA NEUROPATHOLOGICA
- Sex Differences in the Pituitary Transforming Growth Factor-β1 System: Studies in a Model of Resistant Prolactinomas
- (2013) M. Victoria Recouvreux et al. ENDOCRINOLOGY
- Estrogen-related genome-based expression profiling study of uterosacral ligaments in women with pelvic organ prolapse
- (2013) Yeo Jung Moon et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- Effects of Estrogen on Bone mRNA Levels of Sclerostin and Other Genes Relevant to Bone Metabolism in Postmenopausal Women
- (2013) Koji Fujita et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Creatine and guanidinoacetate reference values in a French population
- (2013) Marie Joncquel-Chevalier Curt et al. MOLECULAR GENETICS AND METABOLISM
- Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder
- (2012) Hiroshi Miyamoto et al. BJU INTERNATIONAL
- Endothelial Expression of Endocan Is Strongly Associated with Tumor Progression in Pituitary Adenoma
- (2012) Aurélie Cornelius et al. BRAIN PATHOLOGY
- Inactivation of X-linked tumor suppressor genes in human cancer
- (2012) Runhua Liu et al. Future Oncology
- Cancer/testis antigen SSX2 enhances invasiveness in MCF-7 cells by repressing ERα signaling
- (2012) Shui Wang INTERNATIONAL JOURNAL OF ONCOLOGY
- Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management
- (2012) Ilyess Zemmoura et al. Pituitary
- Integrated Genomic Profiling Identifies Loss of Chromosome 11p Impacting Transcriptomic Activity in Aggressive Pituitary PRL Tumors
- (2011) Anne Wierinckx et al. BRAIN PATHOLOGY
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells
- (2010) Osamu Ikeda et al. CANCER SCIENCE
- Unphosphorylated STAT and heterochromatin protect genome stability
- (2010) Shian-Jang Yan et al. FASEB JOURNAL
- Interactions of STAP-2 with Brk and STAT3 Participate in Cell Growth of Human Breast Cancer Cells
- (2010) Osamu Ikeda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prognostic Factors in Prolactin Pituitary Tumors: Clinical, Histological, and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started